Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,693 | -12,209 | -49,197 | -38,871 | -21,128 |
| Depreciation Amortization | -820 | -401 | -416 | -22 | 108 |
| Accounts payable and accrued liabilities | 695 | -459 | -361 | -1,285 | -1,076 |
| Other Working Capital | 2,094 | -842 | 608 | -35 | -3,105 |
| Other Operating Activity | 3,394 | 2,571 | 13,909 | 12,659 | 4,804 |
| Operating Cash Flow | $-19,330 | $-11,340 | $-35,457 | $-27,554 | $-20,397 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,181 | -7,350 | -53,821 | -53,618 | -1,562 |
| PPE Investments | -189 | N/A | -45 | -45 | -44 |
| Investing Cash Flow | $-3,370 | $-7,350 | $-53,866 | $-53,663 | $-1,606 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 19,986 | N/A | N/A |
| Common Stock Issued | 220 | 16 | 2,556 | 1,135 | 32 |
| Financing Cash Flow | $220 | $16 | $22,542 | $1,135 | $32 |
| Beginning Cash Position | 36,773 | 36,773 | 103,554 | 103,554 | 103,554 |
| End Cash Position | 14,293 | 18,099 | 36,773 | 23,472 | 81,583 |
| Net Cash Flow | $-22,480 | $-18,674 | $-66,781 | $-80,082 | $-21,971 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,330 | -11,340 | -35,457 | -27,554 | -20,397 |
| Capital Expenditure | -189 | N/A | -45 | -45 | -44 |
| Free Cash Flow | -19,519 | -11,340 | -35,502 | -27,599 | -20,441 |